Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
Tyrosine Kinase Assay Kits | MBL Life Sience -ASIA-
Frontiers | HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
What Is MET? - MET Crusaders
c-Met inhibitor - Wikipedia
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence | Oncogene
Frontiers | Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors | ACS Omega
IJMS | Free Full-Text | HGF/c-MET Signaling in Melanocytes and Melanoma
C-Met - wikidoc
c-Met Archives - Network of Cancer Research
Kimono Style: The John C. Weber Collection - The Metropolitan Museum of Art
c-Met Archives - Network of Cancer Research
C-Met - Wikipedia
c-Met Monoclonal Antibody (3D4) (37-0100)
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
BMS-794833 | 99.84%(HPLC) | In Stock | c-Met inhibitor
IJMS | Free Full-Text | HGF/c-MET Signaling in Melanocytes and Melanoma
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities | Molecular Cancer | Full Text
MET targeting: time for a rematch | Oncogene
MET met proto-oncogene (hepatocyte growth factor receptor)
About the MET Mark - Eurofins E&E North America
Products Archive - Met One Instruments
Artificial human Met agonists based on macrocycle scaffolds | Nature Communications
